The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot induction regimen incorporating dinutuximab and sargramostim for the treatment of newly diagnosed high-risk neuroblastoma: A report from the Children's Oncology Group.
 
Sara Michele Federico
No Relationships to Disclose
 
Arlene Naranjo
Consulting or Advisory Role - Novartis
 
Fan Zhang
No Relationships to Disclose
 
Araz Marachelian
Research Funding - Pfizer (Inst); United Therapeutics (Inst)
 
Ami Vijay Desai
Stock and Other Ownership Interests - Pfizer; Viatris
Consulting or Advisory Role - Ology Medical Education; Ymabs Therapeutics Inc
Research Funding - Actuate Therapeutics (Inst); GlaxoSmithKline (Inst); Jubilant DraxImage (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Ymabs Therapeutics Inc (Inst)
 
Hiroyuki Shimada
No Relationships to Disclose
 
Steve E. Braunstein
No Relationships to Disclose
 
Christopher L Tinkle
Research Funding - Kazia Therapeutics
 
Gregory A Yanik
Research Funding - Jazz Pharmaceuticals
 
Shahab Asgharzadeh
No Relationships to Disclose
 
Paul M. Sondel
Research Funding - Invenra (Inst)
Patents, Royalties, Other Intellectual Property - I am an unpaid medical advisor to Invenra Inc. a monoclonal antibody biotech firm in Madison WI. My UW lab is collaborating with Invenra and receiving research reagents from them for mutual research. (Inst); I have partial interest in patents related to my work at the University of Wisconsin-Madison WI, that are held by and managed by the University of Wisconsin Foundation
(OPTIONAL) Uncompensated Relationships - Invenra
 
Alice L. Yu
Leadership - OPKO Health
Stock and Other Ownership Interests - OPKO Health/GeneDx
Honoraria - EUSA Pharma
Consulting or Advisory Role - OBI Pharma
Speakers' Bureau - EUSA Pharma
Research Funding - United Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - cancer targeting peptides; Globo H-Diphtheria toxoid vaccine for cancer therapy; Methods for suppressing cancer by inhibition of TMCC3; NKT stimulatory phenyl-glycolipids for cancer therapy and vaccine adjuvant
Travel, Accommodations, Expenses - EUSA Pharma
 
Michael Acord
No Relationships to Disclose
 
Marguerite T. Parisi
No Relationships to Disclose
 
Barry L. Shulkin
Consulting or Advisory Role - Navidea
 
Steven G. DuBois
Consulting or Advisory Role - Amgen; Bayer
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Rochelle Bagatell
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Julie R. Park
No Relationships to Disclose
 
Wayne Lee Furman
No Relationships to Disclose
 
Suzanne Shusterman
Stock and Other Ownership Interests - Amgen (I); BioTelemetry (I); Bristol-Myers Squibb (I); Evofem (I); GlaxoSmithKline (I); Intuitive Surgical (I); InVitae (I); Kindred Biosciences (I); Merck (I); Nuvasive (I); OPKO Health (I); Regeneron (I); RTI Health Solutions (I); Surgalign (I)